DaVita Inc. (DVA) delivered mixed results in Q2 FY2026 on revenue of $3.6B versus the $3.5B estimate (+5.2% YoY) and EPS of $4.02. The next DaVita Inc. (DVA) earnings date is Oct 29, 2026. Below is the full DaVita Inc. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
DaVita Inc. (DVA) Earnings Analysis — key stats
Next earnings date
Oct 29, 2026
Latest reported quarter
Q2 FY2026
Earnings verdict
Mixed
EPS beat rate
6 of last 8 (quarters above estimate)
Avg next-day move
±13.0% (over the last 8 reports)
Post-earnings direction
Up 3 / Down 5 (of the last 8 reports)
Implied move (next report)
±4.6% (options-derived · into Oct 29, 2026)
Institutional ownership
91.7% (13F as of 2026-06-30)
Top 10 holders
64.6% (of shares outstanding)
Insider activity
8 buys / 4 sells (recent Form 4 filings)
Revenue
$3.6B (vs $3.5B est · +1.7% surprise · +5.2% YoY)
EPS
$4.02 (vs $3.88 est · +3.6% surprise · +56.5% YoY)
Share price
$185.33 (-0.4%)
Market cap
$11.8B
DaVita Inc. (DVA) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$3.6B vs $3.5B est
$4.02 vs $3.88 est
+3.6%
-19.3%
Mixed
Q2 FY2026
$3.4B vs $3.4B est
$2.87 vs $2.41 est
+19.1%
+25.8%
Mixed
Q1 FY2026
$3.6B vs $3.5B est
$3.40 vs $3.24 est
+4.9%
+23.2%
Beat
Q4 FY2025
$3.4B vs $3.4B est
$2.51 vs $3.17 est
-20.8%
-8.4%
Mixed
Q3 FY2025
$3.4B vs $3.4B est
$2.95 vs $2.70 est
+9.3%
-8.4%
Mixed
Q2 FY2025
$3.2B vs $3.2B est
$2.00 vs $1.95 est
+2.6%
+0.2%
Mixed
Q1 FY2025
$3.3B vs $3.3B est
$2.24 vs $2.14 est
+4.7%
-8.5%
Mixed
Q4 FY2024
$3.3B vs $3.3B est
$2.59 vs $2.72 est
-4.8%
-10.1%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Berkshire Hathaway INC
44.6%
28.9M
$6.4B
-4.1%
Blackrock, INC.
3.8%
2.5M
$547.5M
-11.1%
Vanguard Capital Management LLC
3.2%
2.1M
$467.5M
-3.6%
Morgan Stanley
2.5%
1.6M
$356.3M
-3.9%
Vanguard Portfolio Management LLC
2.1%
1.4M
$306.6M
-6.9%
State Street Corp
2.0%
1.3M
$294.3M
-2.1%
Invesco Ltd.
1.9%
1.2M
$269.6M
-17.4%
Dimensional Fund Advisors LP
1.8%
1.1M
$253.1M
-0.7%
Neuberger Berman Group LLC
1.4%
926K
$205.8M
+74.0%
Lsv Asset Management
1.4%
908K
$202.1M
-2.4%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Maughan David Paul
officer: Chief Operating Officer, DKC
2026-09-22
Sell
8K
$1.4M
Hollar Jason M.
director
2026-08-15
Buy
278
—
DESOER BARBARA J
director
2026-08-15
Buy
278
—
Schechter Adam H
director
2026-08-15
Buy
278
—
Moore Gregory J.
director
2026-08-15
Buy
278
—
Pullin Dennis W
director
2026-08-15
Buy
278
—
Schoppert Wendy Lee
director
2026-08-15
Buy
278
—
Arway Pamela M
director
2026-08-15
Buy
278
—
What you'll find
Next DaVita Inc. (DVA) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment DaVita Inc. reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in DaVita Inc. (DVA)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is DaVita Inc.'s next earnings date?
DaVita Inc.'s (DVA) next scheduled earnings date is Oct 29, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did DaVita Inc. (DVA) beat or miss earnings?
In Q2 FY2026, DaVita Inc. (DVA) posted mixed results — revenue of $3.6B versus the $3.5B estimate (+1.7% surprise) and EPS of $4.02 versus $3.88 expected (+3.6% surprise). Magnisto decodes every DaVita Inc. (DVA) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does DaVita Inc. beat earnings estimates?
Over its last 8 reported quarters, DaVita Inc. (DVA) beat Wall Street EPS estimates 6 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every DaVita Inc. (DVA) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does DaVita Inc. stock move after earnings?
Over its last 8 quarterly reports, DaVita Inc. (DVA) moved an average of ±13.0% the day after earnings — ranging from -19.3% (Q3 FY2026) to +25.8% (Q2 FY2026). The stock rose after 3 of those 8 reports and fell after 5. Heading into its next report on Oct 29, 2026, options-implied volatility is pricing in a move of roughly ±4.6% (derived). Magnisto tracks the realized post-earnings move for every DaVita Inc. (DVA) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of DaVita Inc.?
Institutions hold about 91.7% of DaVita Inc.'s (DVA) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Berkshire Hathaway INC (44.6%), Blackrock, INC. (3.8%), Vanguard Capital Management LLC (3.2%). Magnisto lists DaVita Inc.'s (DVA) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling DaVita Inc. (DVA)?
In the most recent Form 4 filings Magnisto tracks, DaVita Inc. (DVA) insiders recorded 8 purchases and 4 sales — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for DaVita Inc. (DVA) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for DaVita Inc. (DVA), anchored to the current $185.33 share price, so you can weigh the bull, base and bear cases for DaVita Inc. side by side.
Is DaVita Inc. (DVA) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether DaVita Inc. fits your own thesis and risk profile. This is research, not investment advice.